X
27Jul

Bio-Rad Geenius HIV 1/2 Implementation

0 Comments | | Return |

CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.

Read all about it on the Communication page by clicking this link: Communications

 

 

Related

CTS Tampa Implements New Laboratory Information System

On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...

Read More >

Phoenix Laboratory Transition to the VISION Analyzer

On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...

Read More >

Reminder- Check flights and cargo hours for the 4th of July Day Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >

Preparing for Hurricane Florence

As the US coast prepares for Hurricane Florence to make landfall, we have received importan...

Read More >

CTS St. Louis Implements New Laboratory Information System

On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...

Read More >

CTS implements Ultrio Plus on the Panther

In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...

Read More >

Subscribe here to receive CTS updates!

Name